about-us

Leadership Team

Leadership Team

Randall C. Schatzman, Ph.D.
President and Chief Executive Officer

Dr. Schatzman has served as our President, Chief Executive Officer and director since he co-founded the company, which commenced operations in January 2004.

John A. Latham, Ph.D.
Chief Scientific Officer

Dr. Latham has served as our Chief Scientific Officer since co-founding Alder BioPharmaceuticals in January 2004.

Mark J. Litton, Ph.D., MBA
Chief Business Officer and Treasurer

Dr. Litton has served as our Chief Business Officer, Treasurer and Secretary since co-founding the company in January 2004.

Jeffrey T.L. Smith, M.D., FRCP
Senior Vice President, Translational Medicine

Dr. Smith has served as our Senior Vice President, Translational Medicine since 2012 and served in other senior management positions from April 2004 to 2012.

Elisabeth A. Sandoval, MBA
Chief Commercial Officer

Ms. Sandoval has served as our Chief Commercial Officer since September 2016.

Timothy M. Whitaker, M.D.
Chief Medical Officer

Dr. Whitaker has served as our Chief Medical Officer since June 2016.

Larry Benedict
Executive Vice President and Principal Accounting Officer

Mr. Benedict joined Alder in 2008 and has served as our Executive Vice President and Principal Accounting Officer since October 2016.

Nancy L. Boman, M.D., Ph.D.
Senior Vice President of Regulatory Affairs and Pharmacovigilance

Dr. Boman has served as our Senior Vice President of Regulatory Affairs and Pharmacovigilance since September 2016.

James B. Bucher, J.D.
Senior Vice President and General Counsel

Mr. Bucher has served as our Senior Vice President and General Counsel since January 2016.

Randy Hassler
 Senior Vice President, Pharmaceutical Operations

Mr. Hassler has served as our Senior Vice President of Pharmaceutical Operations since August 2014.
Menu
×